Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


GSK Consumer's new ANZ boss

Posted 10 October 2019

GSK's joint consumer venture with Pfizer has announced a new local boss starting from the end of October after current area general manager Andrew Jenkin departs "to pursue a new opportunity". 

Anish Patel will take the reins of the venture on 31 October after working as Bayer Consumer's general manager North Asia, GSK said.

Anish Patel

Patel brings over two decades' experience in OTC and FMCG industries to the role, spending over a decade at Bayer Consumer Health ANZ in senior leadership roles including general management, strategy, marketing and finance.

His credentials include a five year stint as Bayer Consumer NZ general manager, where he was also president of the NZ Self Medication Industry during his tenure. 

"The coming together of the GSK and Pfizer consumer healthcare businesses is a significant moment for the ANZ consumer healthcare industry and the newly established joint venture business," Patel said.

"I am excited and honoured to have been chosen to lead this new business not only through this transformation, but for what I hope is many years to come."

GSK consumer healthcare's regional head Keith Choy said Patel "has a clear track record of success and has demonstrated a strong ability to drive engagement and performance through strategic and organisational changes that will be key attributes as he leads the new Joint Venture business across Australia and New Zealand". 

Outgoing general manager Andrew Jenkin also welcomed Patel, saying "it is an exciting time for the business, and I wish the team all the best for the future". 

Jenkin was Pfizer Consumer Healthcare ANZ's general manager when the joint GSK and Pfizer venture was finalised in August, and named chief of the new business at the same time. 

GSK would not comment on where Jenkin was heading. 

Other moves

MTP Connect has hired former pharma communications manager Caroline Duell as its new director of communications and events this week. 

Duell was formerly a senior consultant at communications firm BBG. She also worked as public affairs lead for BMS ANZ prior to that, and held the role of corporate communications director at GSK in the UK.

And Belinda Wood departed the Pharmaceutical Society of Australia (PSA) as its deputy CEO last Friday. 

While Wood says she has no firm plans, she told Pharma in Focus she is "looking forward to what the future holds."

"I am extremely proud of my achievements at PSA and the time is right for me to move on to the next stage in my career," she said.

Wood took on the PSA role last year after being at the helm of the GBMA for three years.

Federal Health Minister Greg Hunt has appointed James Perrin senior media adviser after Lema Samander decided to pursue global travels.  Samander, who stepped up to replace Ben Wicks when he moved to the Prime Minister's office, took extended leave after the election. Matthew Kelly is supporting Perrin.

Shadow health spokesperson Chris Bowen has also fleshed out his office, taking on Catherine King's former chief of staff Andrew Garrett in August, who joins Bowen's media adviser Liz Fitch. 

Melbourne biotech AdAlta this week also announced the appointment of Dr Tim Oldham as CEO and managing director. Oldham previously worked as managing director of Cell Therapies, was president Asia Pacific of Hospira for five years, and worked in senior management roles at Mayne Pharma in Europe. 

Yajun Ma 

Approvals Action
First copy of Faslodex
Sandoz first to copy AZ's breast cancer drug.
Top of the Hill
Take the road less travelled
Which path will pharma leaders choose?